Loading video...

Video Failed to Load

Go Home

Discovered through Navy dolphin research, deficiency in pentadecanoic acid accelerates aging. Fatty15 replenishes this essential molecule, supporting longevity and healthier aging—start your daily supplement today - go to for discounts! #Fatty15 #DrDrewApproved #sponsor

67,936 views • 1 year ago •via X (Twitter)

6 Comments

WCG's profile picture
WCG1 year ago

This really does work. My husband, in his 80s, had tried everything. Supplements, diet, exercise and nothing would get his blood sugar down below 120. He's been on this for several months and his fasting blood sugar is now between 102 and 106. And, I'm not getting paid anything for saying this.

NOVOS Labs's profile picture
NOVOS Labs1 year ago

With NOVOS, healthy aging is simple: one habit, endless benefits. Feel better, live stronger, and trust the science behind every step.

Allison 🖖's profile picture
Allison 🖖1 year ago

Is this an episode of Drunk History?

Colleen's profile picture
Colleen1 year ago

Dr. Drew, FYI someone is using your good name to spam call me saying they're a producer and you want me on your show.

Do Van Hong's profile picture
Do Van Hong1 year ago

Sounds fascinating! It's amazing how research can lead to new breakthroughs. Here’s to healthier aging!

John Boardman's profile picture
John Boardman1 year ago

Dr Drew, you need to start promoting Rapamycin. My wife and I have been on it for 5 years. Amazing results so far. Great science backing it up.

Related Videos

Today’s guest on the Free Radicals podcast is Michael Ringel, JD PhD, COO Life Biosciences and former Managing Director at Boston Consulting Group. Michael is a leader in longevity and pharma who spent 25+ years advising top pharma companies on their R&D strategy. He is now COO at Life Biosciences where he is bringing the first ever partial epigenetic reprogramming therapy to human clinical trials - a major milestone for the longevity industry. In this episode, we discuss Michael’s insightful paper on why aging is an optimization by evolution, why that means it’s malleable, and how to push the longevity field forward. Michael also sits on the US board of Hevolution Foundation and on the board of the AFAR. Be sure to follow me and Eric Dai to stay up to date on the latest news in longevity biotech! 0:00 Intro 2:30 Why aging is an optimization by evolution 15:10 Why scientists miss the role of evolution in aging 19:31 Evidence that aging is a regulated process 24:40 Hormesis and adaptive stress responses 28:55 The promise of partial epigenetic reprogramming in humans 35:08 Life Bio's first therapy proceeding to clinical trials 47:47 Why targeting the eye, particularly glaucoma and NION, is a strategic choice 52:03 The pharma industry's perspective on anti-aging research 56:39 The importance of public engagement for funding and policy change 1:05:42 Reasons for optimism in longevity 1:08:26 Advice on how to have an impactful and interdisciplinary career 1:11:54 The ethical case for longevity 1:17:34 Concrete steps for audience members to support longevity research

Daniel Shur

16,967 views • 4 months ago